Shandong Weigao Orthopaedic Device Co., Ltd Share Price

Equities

688161

CNE1000050W9

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
24.69 CNY +1.11% Intraday chart for Shandong Weigao Orthopaedic Device Co., Ltd +7.82% -40.43%

Financials

Sales 2024 * 1.5B 207M 16.56B Sales 2025 * 1.78B 246M 19.61B Capitalization 9.85B 1.36B 109B
Net income 2024 * 250M 34.53M 2.76B Net income 2025 * 328M 45.3M 3.62B EV / Sales 2024 * 6.56 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 5.54 x
P/E ratio 2024 *
39.8 x
P/E ratio 2025 *
30.1 x
Employees 2,210
Yield 2024 *
0.49%
Yield 2025 *
1.01%
Free-Float 10.54%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Shandong Weigao Orthopaedic Device Co., Ltd's Equity Buyback Plan announced on August 30, 2023. CI
Weigao Orthopaedic Device Names Chairman MT
Weigao Orthopaedic Device's Chairman Resigns MT
Weigao Orthopaedic Device's Profit Slumps 81.5% in 2023 MT
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Shandong Weigao Orthopaedic Device Co., Ltd's Equity Buyback Plan announced on August 30, 2023. CI
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Shandong Weigao Orthopaedic Device Co., Ltd's Equity Buyback Plan announced on August 30, 2023. CI
Shandong Weigao Orthopaedic Device Co., Ltd(XSSC:688161) added to S&P Global BMI Index CI
Shandong Weigao Orthopaedic Device Co., Ltd announces an Equity Buyback for CNY 120 million worth of its shares. CI
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shandong Weigao Orthopaedic Device Co., Ltd authorizes a Buyback Plan. CI
Shandong Weigao Orthopaedic Device Co., Ltd's Board intends to launch an Equity Buyback Plan. CI
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
1 day+1.11%
1 week+7.82%
Current month-3.37%
1 month-3.37%
3 months-28.37%
6 months-40.07%
Current year-40.43%
More quotes
1 week
23.45
Extreme 23.45
24.88
1 month
22.50
Extreme 22.5
27.48
Current year
22.50
Extreme 22.5
41.52
1 year
22.50
Extreme 22.5
57.44
3 years
22.50
Extreme 22.5
124.80
5 years
22.50
Extreme 22.5
124.80
10 years
22.50
Extreme 22.5
124.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 31/08/18
Director of Finance/CFO 53 26/10/23
Chief Tech/Sci/R&D Officer 41 31/01/14
Members of the board TitleAgeSince
Director/Board Member 62 28/12/22
Director/Board Member 50 25/03/20
Chief Executive Officer 50 31/08/18
More insiders
Date Price Change Volume
26/04/24 24.69 +1.11% 1,058,436
25/04/24 24.42 +0.95% 798,353
24/04/24 24.19 +0.21% 695,639
23/04/24 24.14 +2.68% 1,028,187
22/04/24 23.51 +2.66% 1,109,133

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Shandong Weigao Orthopaedic Device Co Ltd is a China-based company mainly engaged in the research and development, production and sales of orthopedic medical devices. The Company's products include orthopedic implanted medical devices and orthopedic surgical instruments. The Company's products cover various orthopedic implanted medical device fields such as spine, trauma, joint and sports medicine, among others. The Company mainly conducts its businesses within domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
24.69
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688161 Stock